Issuance of Stock Acquisition Rights to Directors and Employees
First written in FY2017-Q3. 12 of 14 entries say "Advanced", first in FY2018-Q2. Latest entry: FY2026.
106 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「A special resolution is scheduled to be submitted to the ordinary general meeting of shareholders to be held on 29 October 2026. The number of stock acquisition rights is capped at 17,400, and the number of common shares underlying them is capped at 1,740,000.」
In addition to the 21st Stock Acquisition Rights approved in January 2026, the Company disclosed a plan for the 22nd Stock Acquisition Rights, capped at 17,400 rights and 1.74 million underlying shares, with a term from 2 years after the allotment date through 31 October 2032. - FY2026-H1AdvancedAnnual report
「Resolution date 23 January 2026 Eligible recipients and number of people Company directors: 7 Directors of subsidiaries: 13 Number of share options※ 16,800 Class, details and number of shares underlying the share options※ Common shares: 1,680,000 Exercise period for the share options※ From 23 January 2028 To 31 October 2031」
Established 16,800 share options for 7 company directors and 13 subsidiary directors, covering 1,680,000 shares, with an exercise period from January 2028 to October 2031. - FY2023-Q2AdvancedAnnual report
「Resolution date 23 December 2022 Eligible recipients and number of people Company directors: 5 Company employees: 1 Directors of subsidiaries: 17 Employees of subsidiaries: 5 Number of share options※ 28,800 Class, details and number of shares underlying the share options※ Common shares: 2,880,000 Exercise period for the share options※ From 5 January 2025 To 31 October 2029」
Established 28,800 share options for directors, employees and subsidiary officers and employees, covering 2,880,000 shares, with an exercise period from 2025 to 2029. - FY2022-Q2AdvancedAnnual report
「Number of share options※ (Note 1) 9,900 Class, details and number of shares underlying the share options※ (Note 2) Common shares: 990,000 Amount payable upon exercise of the share options (yen)※ (Note 3) 151 Exercise period for the share options※ From 5 January 2024 To 31 October 2028」
For the share options resolved on 23 December 2021, established 9,900 options for directors, employees and subsidiary directors, covering 990,000 shares, with an exercise period from 5 January 2024 to 31 October 2028. - FY2021AdvancedAnnual report
「Issue price per share and amount transferred to capital when shares are issued upon exercise of the share options (yen) Issue price: 155 Amount transferred to capital: 78」
During the current fiscal year, 1,139,000 shares were issued upon exercise of previously issued share options, with treasury shares delivered. In addition, share options covering 2,570,000 shares were established for the grants made in December 2020. - FY2021-Q2AdvancedAnnual report
「Resolution date 16 December 2020 Eligible recipients and number of people Company directors: 7 Company employees: 2 Directors of subsidiaries: 25 Number of share options: 25,700 Class, details and number of shares underlying the share options Common shares: 2,570,000 Exercise period for the share options From 24 December 2022 To 31 October 2027」
Based on the resolution of 16 December 2020, established 25,700 share options for directors, employees and subsidiary directors, covering 2,570,000 shares. - FY2020AdvancedAnnual report
「Resolution date 29 October 2020 (17th series of share options) Number of share options Up to 30,000 Number of shares underlying the share options Common shares Up to 3,000,000 shares」
For the 17th series of share options, established a maximum of 30,000 options for directors, employees and officers of affiliated companies, covering a maximum of 3,000,000 shares, with an exercise period from 2 years after the allotment date through 31 October 2027. - FY2019AdvancedAnnual report
「Resolution date 24 October 2019 (17th series of share options) Number of share options Up to 30,000 Number of shares underlying the share options Common shares Up to 3,000,000 shares」
For the 17th series of share options, established a maximum of 30,000 options for directors, employees and officers of affiliated companies, covering a maximum of 3,000,000 shares, with an exercise period from 2 years after the allotment date through 31 October 2026. - FY2019-Q2AdvancedAnnual report
「Resolution date 17 December 2018 Eligible recipients and number of people Company directors: 8 Company employees: 9 Directors of subsidiaries: 16 Number of share options 28,600 Class, details and number of shares underlying the share options Common shares: 2,860,000 Exercise period for the share options From 25 December 2020 To 31 October 2025」
Established 28,600 share options for directors, employees and others, covering 2,860,000 shares, with an exercise period from 25 December 2020 to 31 October 2025. - FY2018AdvancedAnnual report
「Number of share options Up to 30,000 Class, details and number of shares underlying the share options Common shares Up to 3,000,000 shares Exercise period for the share options From the date 2 years after the allotment date To 31 October 2025」
For the 16th series of share options resolved on 25 October 2018, established a maximum of 30,000 options for directors, employees and others, covering a maximum of 3,000,000 shares, with an exercise period from 2 years after the allotment date through 31 October 2025. - FY2018-Q2AdvancedAnnual report
「Resolution date 15 December 2017 Number of share options 28,550 Number of shares underlying the share options 2,855,000 Exercise period for the share options From 25 December 2019 To 31 October 2024」
Based on the resolution of 15 December 2017, issued 28,550 share options to directors, employees and others, covering 2,855,000 shares. - FY2017-Q3First statedAnnual report
「Resolution date 18 January 2017 Number of share options 30,000 Number of shares underlying the share options 3,000,000 Exercise period for the share options From 6 February 2019 To 31 October 2023」
Issued 30,000 share options to directors, employees and others, covering 3,000,000 shares, with an exercise period from 6 February 2019 to 31 October 2023.